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ABSTRACT 
A Simple Facile One-pot reaction, novel and efficient rout for the synthesis of substituted pyrazolo [3, 4-d] pyrimidines, and 
pyrazolo [3, 4-b] pyridines, results from reaction of substituted-5-amino-4-cyanopyrazoles with malononitrile and 
diethylmalonate respectively. The structures of the products and conceivable mechanisms are discussed. The 
antibacterial activity of some new synthesized compounds was evaluated and seemed to be significant. 
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Academic Discipline And Sub-Disciplines 
Organic Chemistry  
SUBJECT  CLASSIFICATION 
Organic Chemistry  
TYPE (METHOD/APPROACH) 
Some new nitrogen bridge-head pyrido[1,2-b][1,2,4]triazepines incorporating 6-methylchromone moiety have been 
synthesized from the reaction of 1,6-diamino-4-(6-methyl-4-oxo-4H-chromen-3-yl)-2-oxo-1,2-dihydropyridine-3,5-
dicarbonitrile (4) with some α,γ-bifunctional electrophiles including 2-cyano-3,3-bis(methylthio)acrylonitrile, 2-cyano-3,3-
bis(methylthio)prop-2-enamide, 5-chloro-3-methyl-1-phenylpyrazole-4-carboxaldehyde, 2-chloro-3-formylquinoline, p-
methoxybenzylidene-malononitrile, ethyl 2-cyano-3-(4-methoxyphenyl)prop-2-enoate, chromone-3-carbonitrile. Structures 
of the newly synthesized products have been deduced upon the help of elemental analysis and spectral data. The 
synthesized compounds were screened for their antimicrobial activity.  
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INTRODUCTION 
Pyrazolopyrimidines are of considerable chemical and pharmacological importance as purine analogues, it is 
a heterocyclic chemical compound with the molecular formula C6H5N3. It forms the central core of a variety of more 
complex chemical compounds including some pharmaceuticals and pesticides
 (1, 2)
. 
 Pyrazolopyrimidines have antitumor, antileukemic activities. The pyrazole containing compounds have practical 
applications in the medicinal and agrochemical field and the biological activity
 (3-5)
 of pyrazoles and its derivatives is well 
documented. The pyrazole ring has shown to be the basic moiety for a number of dyes, drugs and anesthetics
 (6, 7)
. Amino 
and hydroxyl substituted pyrazoles have been used as choline esterase inhibitors
8
. Pyrazolopyridines and its 
hydroderivatives are very interesting pyrazole derivatives with wide ranging biological activities
9
. A number of pyrazolo [3, 
4-b] pyridines exhibit a wide range of biological activities, including interesting anxiolytic activity (e.g. tracazolate), 
dopamine D3 receptor antagonist, antiherpetic and antiallergic properties
10
. 
The pyrazolo [3,4-b] pyridine system has interesting biological and pharmacological properties
11
, such as ACTH 
(adrenocorticotropic hormone) - releasing factor (CRF) (corticotropin-releasing factor)) antagonist activity; CRF 
antagonists are believed to be effective in the treatment of a wide variety of stress-related illnesses, such as depression, 
Alzheimer’s disease, gastrointestinal diseases, anorexia nervosa, hemorrhage stress, drug and alcohol withdrawal 
symptoms, drug addiction and infertility
12
. For this purpose we started from the key intermediates (1a–c) (substituted-5-
amino-4-cyanopyrazoles) (Scheme 1) and reacted them with malononitrile and diethylmalonate to obtain pyrazolo [3, 4-d] 
pyrimidines and pyrazolo[3,4-b]pyridines respectively. 
RESULTS AND DISCUSSION 
The aim of this work, The 5-amino-1H-pyrazole-4-carbonitrile (1), were used as starting materials, which 
contains a cyano group in the ortho position is required for the synthesis of the condensed systems including pyridine and 
pyrimidine, with malononitrile and diethylmalonate. 
In ethanolic sodium ethoxide solution, compounds (1a) and (1b) reacted with malononitrile to afford pale brown powders of 
mp 235-237 
o
C for (2a) and 289-291
o
C for (2b), respectively. The 
1
H NMR spectrum of compound (2a) revealed a 
methylene singlet at (d) 4.17 ppm and pyrazole H-3 as a singlet at 8.35 ppm. Two singlet appear, one NH2 group at 8.07-
8.10 ppm and other at 11.04 for NH as expected. Based on these data it seemed that a –CH2CN side chain is present and 
that the cyclization took. By addition of the NH2 in the pyrazole (1) to the CN of the malononitrile to form the amidine 
intermediate followed by an attack of the newly formed amino group to the CN of (1) to afford the pyrazolopyrimidine (2), 
as shown in Scheme 1. On the contrary, reaction of compounds (1a, b) with diethylmalonate in ethanolic sodium ethoxide 
solution gave pyrazolopyrimidines (3a, b). The structure of compounds (3) was confirmed by 
1
HNMR spectroscopic data. 
The 
1
HNMR spectrum of compound (3a) revealed the ester group as a triplet for the CH3 protons at 1.37 ppm and a 
quartet for the CH2 protons at 4.48 ppm, pyrazole H-3, one NH2 group, and an OH signal at 12.42 ppm (Scheme 1)
13
. It 
has been found that when compound (1a) refluxing in ethanol in the presence of triethylamine afforded a brown crystalline 
solid of mp 247-249 
o
C. It was expected that this reaction would give the pyrazolopyrimidine (4a). However, the micro-
analytical data showed that this product has the molecular formula C8H8N8. Furthermore, the IR spectrum displays an 
absorption at 3472 and 3312 cm-1, corresponding to NH2 stretching and at 3212 for (NH) cm
-1
and no CN absorption. The 
1
HNMR spectrum reveals two singlets for the amino groups at 5.77 and 5.99 ppm and two singlets for the pyrazole H-3 
protons. Structure (4a) was thus suggested for this product. The formation of compound (4a) may be envisaged via initial 
condensation of the amino group of one molecule of the o-aminonitrile with the cyano group of a second molecule to give 
an intermediate amidine which then undergoes a second, but intramolecular, amine-nitrile condensation to give the 
isolated product. A similar result had been established by Taylor and Borror in the formation of (4a) (Scheme 1)
14
. 
Compounds (1b-c) were refluxed under the same reaction conditions to afford (4b-c). Similar cyclizations with other 
nitriles have been reported
15
. In an attempt to introduce a formyl group at position 3 in pyrazole (1), aminopyrazole (1) was 
reacted with Vilsmeier reagent (DMF-POCl3) at 70ºC for 3h. To the product which was obtained structure (6) was 
proposed based on the NMR data which indicate the presence of OH group and the pyrazole H-3, the reaction proceeding 
via the intermediacy of (5) (Scheme 2).  
EXPERIMENTAL 
General Procedures. Melting points are uncorrected. Microanalyses were carried out in the Microanalytical Centre, 
Cairo University, Egypt. IR (KBr) spectra were measured on a Karl Zeiss IMP 16 spectrophotometer. 1H-NMR spectra 
were measured by using Jeol 
Spectrometer EX-270. Double resonance, HMQC and HMBC experiments were carried out for complete assignment of 
proton and carbon signals in the NMR spectra, whenever possible. Elemental analyses were obtained on a Leco CHNS-
932 instrument. Compound 9 was prepared by a known method
16
. 
General procedure for preparation of 2a, b and 3a, b 
Compound 5-amino-4-cyano-1-H-pyrazole (1a,b), (10 mmol) was added  to (10 mmol) malononitrile or diethylmalonate, 
this mixture was added to 10 mL freshly prepared sodium ethoxide solution prepared by adding 0.5 g sodium metal into 
absolute ethanol (10 mL) and the mixture was refluxed for 5 h, and left to cool overnight. The solid product so formed was 
collected by filtration, washed with ethanol and crystallized from ethanol, unless otherwise stated
17
. 
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Data: 
(4-Amino-1H-pyrazolo [3, 4-d] pyrimidin-6-yl)-acetonitrile (2a): Pale brown crystals (87%) mp 235-237oC 
(EtOH). Anal. Calcd for: C7H6N6 (174.17): C, 48.27; H, 3.71; N, 48.25 %. Found: C, 48.45; H, 3.65; N, 48.46 %.IR (KBr) v 
= 3453 and 3292 (NH2), 2215 (CN), 3202 (NH) cm
-1
. δH (DMSO-d6): 4.17 (s, 2H, CH2), 8.00 (br s, 1H, NH2), 8.07 (br s, 2H, 
NH2), 8.10-8.25, 8.35 (s, 1H, H-3) (br s, 1H, NH2), 11.04 (s, 1H, NH); δC (DMSO-d6): 27.88 (CH2), 101.13 (C-3a), 118.61 
(CN), 135.13 (C-3), 154.78 (C-7a), 159.99 (C-4), 158.55 (C-6). 
(4-Amino-1-phenylpyrazolo [3, 4-d] pyrimidin-6-yl)-acetonitrile (2b): 
Brown powder (83%) mp 289-291
o
C (EtOH). Anal. Calcd for: C13H10N6 (250.26): C, 62.39; H, 4.03; N, 33.58. Found C, 
62.43; H, 4.18; N, 33.48. IR (KBr) v: 3462 and 3302, (NH2), 2216 (CN) cm-1; δH (DMSO-d6): 4.14 (s, 2H, CH2),7.23 (t, 1H, 
H-4
/
), 7.51 (d, 2H, H-3
/
, H-5
/
), 8.12 (br, 2H, NH2), 8.27 (d, 2H, H-2
/
, H-6
/
), 8.35 (s, 1H, H-3) ); δC (DMSO-d6): 27.91 (CH2), 
100.89 (C-3a), 117.88 (CN), 134.88 (C-3), 154.21 (C-7a), 158.21 (C-4), 159.22 (C-6), 121.46 (C-2
/
, C-6
/
), 123.22 (C-4
/
), 
128.99 (C-3
/
, C-5
/
), 133.22 (C-1
/
). 
4-Amino-6-hydroxy-1H-pyrazolo [3, 4-b] pyridine-5-carboxylic acid ethyl ester (3a): 
White powder (87%) mp 192-194
o
C (EtOH); Anal. Calcd for: C9H10N4O3 (222.21): C, 48.65; H, 4.54; N, 25.21; O, 21.60%. 
Found: C, 49.19; H, 4.48; N, 25.41 %. IR (KBr) v: 3212 (NH), 3510 and 3392, (NH2), 3236 (br, OH), 1661 (C=O) cm-1; δH 
(DMSO-d6): 1.37 (t, 3H, CH3), 4.48 (q, 2H, CH2), 8.16 (s, 2H, NH2), 8.54 (s, 1H, H-3), 12.42 (br, s, 1H, OH); δC (DMSO-
d6): 14.99 (CH3), 62.22 (CH2), 101,29 (C-3a), 134.99 (C-3), 149.22 (C-7a), 153.22 (C-4), 165.22 (C-6), 171.22 (C=O).  
4-Amino-6-hydroxy-1-phenyl-1H-pyrazolo [3, 4-b] pyridine-5-carboxylic acid ethyl ester (3b): 
White powder (88%) mp 304-305
o
C (EtOH); Anal. Calcd for: C15H14N4O3 (298.30): C, 60.40; H, 4.73; N, 18.78; O, 16.09 
%. Found: C, 60.55; H, 4.83; N, 18.68 %. IR (KBr) v: 3212 (NH), 3487 and 3364, (NH2), 3178 (br, OH), 1677 (C=O) cm-1; 
δH (DMSO-d6): 1.33 (t, 3H, CH3), 4.37 (q, 2H, CH2), 7.35 (t, 1H, H-4
/
), 7. 51 (t, 2H, H-3
/
), 8.16 (d, 4H, H-2
/
, H-6
/
), 8.55 (s, 
1H, H-3), 8.44 (s, 1H, H-3), 12.85 (br s, 1H, OH); δC (DMSO-d6): 14.29 (CH3), 61.99 (CH2), 102.10 (C-3a), 135.22 (C-3), 
149.59 (C-7a), 154.10 (C-4), 165.99 (C-6), 120.22 (C-2
/
, C-6
/
), 123.99 (C-4
/
), 128.22 (C-3
/
, C-5
/
), 140.21 (C-1
/
), 170.99 
(C=O). 
General procedure for preparation of 4a-c:  
To a solution of 5-amino-4-cyano- pyrazole (1a-c) (0.1 mol), in ethanol (10mL) and triethylamine (1 mL) was heated under 
reflux for 7 h and then concentrated under reduced pressure. The solid product so formed was collected by filtration, washed 
with ethanol and crystallized from EtOH-H2O
17
. 
6-(5-Amino-1H-pyrazol-4-yl)-7H-pyrrolo [2, 3-d] pyrimidin-4-ylamine (4a): 
Brown powder (87%) mp 247-249
o
C (EtOH); Anal. Calcd for: C8H8N8 (216.21): C, 44.44; H, 3.73; N, 51.83%. Found C, 44.34; 
H, 3.79, N; 51.40 %. IR (KBr) v: 3472 and 3312, (NH2), 3212 (NH) cm-1; δH (DMSO-d6): 5.77 (s, 2H, NH2-C-5
//
), 5.99 (s, 2H, 
NH2-C-4), 8.02 (s, 1H, H-3
//
), 8.28 (s, 1H, H-3), 11.13 (s, 2H,NH); δC (DMSO-d6): 104.21 (C-3a), 141.13 (C-3), 146.22 (C-7a), 
155.22 (C-5
//
), 157.94 (C-4), 160.93 (C-6). 
6-(5-Amino-1-phenyl-1H-pyrazol-4-yl)-1-phenyl-1H-yrazolo [3, 4-d] pyrimidin-4-ylamine (4b): 
Pale brown powder (77%) mp 267-269
o
C (EtOH); Anal. Calcd for: C20H16N8 (368.40): C, 65.21; H, 4.38; N, 30.42 %. 
Found: C, 65.41; H, 4.28; N, 30.62 %. IR (KBr) v: 3472 and 3312, (NH2) cm-1; δH (CDCl3): 6.57 (s, 2H, NH2-C-5
//
), 6.01 
(s,2H, NH2-C-4), 7.55-7.62 (m, 2H, Ar-H), 7.88 (appt, 4H, Ar-H), 7.80-7.87 (m, 2H,Ar-H), 8.62 (s, 1H, H-3``), 8.71 (d, 2H, 
Ar-H), 8.23 (s, 1H, H-3); 
δC (CDCl3): 95.04 (C-4``), 102.38 (C-3a), 120.72 (C-2
/
, C-6
/
or C-2
///
, C-6
///
), 122.58 (C-2
/
, C-6
/
or C-2
///
, C-6
///
), 125.46 (C-
4
/
or C-4
///
), 126.69 (C-4
///
or C-4
/
), 128.66 (C-3
/
, C-5
/
 or C-3
///
, C-5
///
), 127.64 (C-3
/
, C-5
/
 or C-3
///
, C-5
///
), 131.33 (C-3
//
), 
137.25 (C-1
/
or C-1
///
), 138.12 (C-1
///
 or C-1
/
), 140.03 (C-3), 146.89 (C-7a), 155.19 (C-5
//
), 157.14 (C-4), 159.42 (C-6). 
6-(5-Amino-1-methyl-1H-pyrazol-4-yl)-1-methyl-1H-yrazolo [3, 4-d] pyrimidin-4-ylamine (4c): 
Brown powder (82%) mp 265-267
o
C (EtOH); Anal. Calcd for: C10H12N8 (244.26): C, 49.17; H, 4.95; N, 45.87 %. Found: C, 
49.19; H, 5.25; N, 45.56 %. IR (KBr) v: 3387 and 3329, (NH2) cm-1; δH (DMSO-d6):  2.45 (3H, s, H3), 2.46 (3H, s, H3), 6.74 
(s, 2H, NH2-C-5’’), 7.45 (br, 2H, NH2-C-4), 7.88 (s, 1H, H-3), 8.36 (s, 1H, H-3’’); δC (DMSO-d6): 20.99 (CH3), 20.61 (CH3), 
98.99 (C-4
//
), 102.99 (C-3a), 121.11 (C-2
/
, C-6
/
), 123.22 (C-2
/
, C-6
/
), 129.33 (C-3
/
, C-5
/
), 130.22 (C-3
/
, C-5
/
), 135.22 (C-4
/
), 
135.99 (C-4
/
), 136.22 (C-1
/
), 135.22 (C-1
/
), 139.99 (C-3), 146.99 (C-7a), 157.55 (C-4), 160.91 (C-6).       
General procedure for preparation of (6a, b): 
10 mmol of (1a, b) was added to phosphoryl chloride (1.915 g, 12.5 mmol) in anhydrous DMF (2.5 mL) was heated under 
stirring at 70
o
C for 3 h. Then, the reaction mixture was poured onto ice and treated with aqueous ammonia (pH 8). A white 
solid separated and it was filtered off, washed with water, dried and recrystallized from an appropriate solvent to afford the 
products in 60–82% yields. 
1H-Pyrazolo [3, 4-d] pyrimidin-4-ol (6a): 
White powder (75%) mp 301-302
o
C (EtOH); Anal. Calcd for: C5H4N4O (136.11): C, 44.12; H, 2.96; N, 41.16; O, 11.75 %. 
Found: C, 44.29; H, 2.75; N, 41.36; O, 11.85 %. IR (KBr) v: 3212 (NH), 3237 (br, OH) cm-1; δH (DMSO-d6): 8.19 (s, 1H, H-
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/
6), 8.45 (s, 1H, H-3), 12.35 (br, 1H, OH); δC (DMSO-d6):106.98 (C-3a), 136.22 (C-3), 149.22 (C-6), 151.23 (C-7a), 158.11 
(C-4). 
1-Phenyl-1H-pyrazolo [3, 4-d] pyrimidin-4-ol (6b): 
White powder (87%) mp 311-312
o
C (EtOH); Anal. Calcd for: C11H8N4O (212.21): C, 62.26; H, 3.80; N, 26.40; O, 7.54 %. 
Found: C, 62.39; H, 3.65; N, 26.56; O, 7.75 %. IR (KBr) v: 3247 (br, OH) cm-1; δH (DMSO-d6): 7.41 (t, 1H, H-4
/
), 7.58 (t, 
2H, H-3
/
 and H-5
/
), 8.13 (d, 2H, H-2
/
, H-6
/
), 8.21 (s, 1H, H-6), 8.39 (s, 1H, H-3), 12.45 (br, 1H, OH). 
3. Antibacterial activity  
The moiety in pyrazole known for their popular pharmacological activities
 (19, 20)
, moiety in pyrazole, both in the form of a 
substituent or as a fused component, changes its properties and converts it into an altogether new and important 
heterocyclic derivative. Pyrimidines have attracted particular interest over the last few decades due to the use of such a 
ring system as the core nucleus in various drugs
19
. They are well considering the importance of pyrazolopyrimidine 
derivatives for their biological activity, it was thought worthwhile to test most of our prepared compounds (2 a,b - 3a,b, 4a-
c, 5a-c, 6a,c) for their antibacterial activity against some bacteria namely Escherichia coli, Pseudomonas aeruginosa, 
Staphylococcus aureus and Enteroccus faecalis. The minimum inhibitory concentrations (MIC) were ascertained by the 
broth dilution method (microdilution using 96-well microplates)
 20
. The results presented in table 1 showed that 3b, 4c were 
the most active towards Pseudomonas aeruginosa. We also noticed that adding a CH2 in the fragment decreases this 
activity. Compound 4c was the most active against E. coli, Acinetobacter, Pseudomonas Aeruginosa, and Staphlococcus 
Aureus. The remaining compounds were found to have a slight or moderate activity against the tested organisms.  
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Table 1 Antibacterial activity of some synthesized compounds 
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